Skip to content

Clinical Efficacy and Mechanism Study of Tiaoshen Acupuncture in Treating Mild Cognitive Impairment in Parkinsons Disease

Clinical Efficacy and Mechanism Study of Tiaoshen Acupuncture in Treating Mild Cognitive Impairment in Parkinsons Disease

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025001822
Enrollment
Unknown
Registered
2025-09-24
Start date
2025-10-20
Completion date
Unknown
Last updated
2025-10-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mild cognitive impairment in Parkinson's disease

Interventions

Acupuncture group:Acupuncture and anti-Parkinsonian drugs
Waiting group:Anti-Parkinsonian drugs

Sponsors

The First Affiliated Hospital of Guangzhou University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1: The clinical diagnosis was confirmed as primary Parkinson's disease; 2: The clinical diagnosis was confirmed as Parkinson's disease with mild cognitive impairment; 3: Age 40-80 years old male or female; 4: PD-CRS score is between 73 and 80 points; 5: MoCA score is between 20 and 25 points; 6: Did not participate in other drugs or acupuncture clinical trials within 1 month prior to inclusion in the study; 7: Participate voluntarily and sign informed consent; 8: For those who have been diagnosed for the first time and have not yet taken anti-Parkinson's drugs a professional physician will formulate a medication plan. Once the symptoms stabilize they will be included in the treatment.

Exclusion criteria

Exclusion criteria: 1: Do not meet the diagnostic criteria and inclusion criteria; 2: Patients taking drugs to improve cognitive function 3: Patients with serious mental diseases such as depression schizophrenia and violent tendencies 4: Cognitive impairment caused by Alzheimer's disease vascular dementia and other diseases 5: Participating in other drug or acupuncture researchers; 6: Patients with Parkinsonism; 7: Patients who are not suitable to participate in this study due to physical conditions.

Design outcomes

Primary

MeasureTime frame
Parkinsons Disease-Cognitive Rating Scale;

Secondary

MeasureTime frame
UPDRS;MoCA;Ach;ChAT;

Countries

China

Contacts

Public ContactZhuang Lixing

The First Affiliated Hospital of Guangzhou University of Traditional Chinese Medicine

zhuanglixing@163.com13822287775

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026